Emerging Markets Report: The Game Changer
One World Pharma (OTCQB: OWPC) has recently received critical growing approvals in Colombia, positioning itself to tap into a vast international market. NBA legend Isiah Thomas, now CEO, has committed $3 million of his personal funds to expand operations, including a state-of-the-art THC/CBD extraction facility. This investment comes after significant corporate milestones and aims to capitalize on exclusive permissions. The company plans to utilize these funds for expanding farm operations and obtaining necessary certifications to generate sales and revenue, marking a potential turning point for its growth.
- Isiah Thomas committed $3 million of his own money to One World Pharma.
- Received critical growing approvals in Colombia, unlocking international market access.
- Plans to expand farm operations and build a state-of-the-art THC/CBD extraction facility.
- None.
An Emerging Markets Sponsored Commentary
ORLANDO, Fla., March 16, 2021 (GLOBE NEWSWIRE) -- In today’s edition of The Emerging Markets report we are getting right to the point regarding One World Pharma Inc. (OTCQB: OWPC) which we believe is unlike any deal we’ve previously presented in our pages. Frankly, a recent event is a true game changer.
First, a quick primer:
- One World Pharma is led by legendary NBA superstar and international businessman Isiah Thomas. Thomas is renowned not just for being one of the greatest basketball players of all time, but for having enormous business successes. His name attached to any deal should turn heads and inspire interest.
- OWP is based in Colombia where as Mr. Thomas says, the perfect equatorial growing conditions give it a huge “home court advantage” to harvest the finest cannabis at scale and sell these ingredients at the most competitive pricing.
- Notably, one World Pharma has just received important growing approvals in Colombia which “…now unlock access to a vast international market that we’ve been waiting to enter.” The company is truly at a tipping point.
- And the game changer is that Thomas just committed to putting THREE MILLION DOLLARS of his own money into the deal.
This game changer, we believe, could be truly transformative for One World Pharma at a point when it appears poised to go to the next level of production and monetization. First, a cash infusion of that significance can help the Company seize the moment and capitalize on its current, highly exclusive permissions. One World Pharma intends to use the funds for expansion of farm operations, additional certifications for THC seeds already approved by the government of Colombia, Global GAP (Good Agricultural Practices) certification and the build-out of a GMP certified state-of-the-art THC/CBD extraction facility.
In short, One World Pharma is going to use the funds to do the things that will generate sales and revenue.
Secondly, it’s important to note the timing of this commitment by Thomas, as it comes quite some time after he took the big chair as CEO in June of 2020. Now, after nine months of running the business, getting hands on experience, and watching the corporate milestones get hit and growing permissions granted, Thomas has made what can only be described as an enormous financial commitment, betting on himself and the Company.
It’s a game changer in the making.
For more information on One World Pharma please visit:
About the Emerging Markets Report:
Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stock brokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.
For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php
Must Read OTC Markets/SEC policy on stock promotion and investor protection
- https://www.otcmarkets.com/learn/policy-on-stock-promotion
- https://www.otcmarkets.com/learn/investor-protection
- https://www.sec.gov/news/press-release/2017-79
- https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.html
Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.
We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies.
EMC has been paid
http://emergingmarketsllc.com/disclaimer.php
Emerging Markets Consulting, LLC
Florida Office
390 North orange Ave Suite 2300
Orlando, FL 32801
E-mail: jamespainter@emergingmarketsllc.com
Web: www.emergingmarketsllc.com
FAQ
What recent developments have occurred with One World Pharma (OWPC)?
How much has Isiah Thomas invested in One World Pharma (OWPC)?
What will One World Pharma (OWPC) do with the $3 million investment?
Who is leading One World Pharma (OWPC)?
